Oncologist counseling practice and COVID‐19 vaccination outcomes for patients with history of PEG‐asparaginase hypersensitivity-Reference-Cited by-同舟云学术

Oncologist counseling practice and COVID‐19 vaccination outcomes for patients with history of PEG‐asparaginase hypersensitivity

Published:2022-03-30 Issue:7 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Zarnegar‐Lumley Sara¹²^ORCID,Stone Cosby A.³,Smith Christine M.¹²^ORCID,Hall Laura L.⁴,Luck Kate E.¹,Koo Grace⁴,Plager Jessica H.⁴,Phillips Elizabeth J.⁵⁶⁷,Friedman Debra L.¹²^ORCID

Affiliation:

1. Division of Hematology and Oncology, Department of Pediatrics Vanderbilt University Medical Center Nashville Tennessee USA

2. Vanderbilt‐Ingram Cancer Center Vanderbilt University Medical Center Nashville Tennessee USA

3. Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

4. Department of Pediatric Pharmacy Pharmacology, Monroe Carell, Jr. Children's Hospital at Vanderbilt Nashville Tennessee USA

5. Division of Infectious Diseases, Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

6. Department of Pathology, Microbiology and Immunology Vanderbilt University School of Medicine Nashville Tennessee USA

7. Institute for Immunology & Infectious Diseases Murdoch University Murdoch Western Australia Australia

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29686

Reference25 articles.

1. Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review

2. Comparison of Hypersensitivity Reactions to PEG-Asparaginase in Children After Intravenous and Intramuscular Administration

3. Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children’s oncology group (COG) clinical trials

4. Reply to: Comment on: Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review

5. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying and Managing Those at Risk for Vaccine-Related Allergy and Anaphylaxis;The Journal of Allergy and Clinical Immunology: In Practice;2023-07